Why Are Moderna Executives Dumping Stock While Developing a Coronavirus Vaccine?

re: Why Are Moderna Executives Dumping Stock While Developing a Coronavirus Vaccine?

poplegendpop — 9/8/2020 8:12:13 PM

Smart move on the execs part, but smacks of insider trading.

re: Why Are Moderna Executives Dumping Stock While Developing a Coronavirus Vaccine?

Chewbakka — 9/8/2020 11:57:04 AM

There is not a single effective vaccine against an RNA genome virus on the market. Not to be confused with the RNA genome of the virus, but mRNA vaccine technologies, despite being in humans for almost a decade, have yet to receive 1 approval; so much for speed. Moderna and other similar companies are riding an academic effort. Just check the pipeplines of BionTech, Moderna and Curevac. Most of their vaccine programs have stalled in Phase 2 and they look the same as they did a few years ago. This technology is not good, and that is why there is so much turnover at these companies and is why the stock is being sold right now. This effort will fail at the most benign, but likely will lead to much higher toxicities over conventional vaccine efforts

re: Why Are Moderna Executives Dumping Stock While Developing a Coronavirus Vaccine?

el-graf — 9/7/2020 12:56:14 AM

Because even though they may be demon-influenced, they are not stupid. They can see the writing on the wall ..... just like Belshazzar.

re: Why Are Moderna Executives Dumping Stock While Developing a Coronavirus Vaccine?

MiketheAngel — 9/6/2020 9:59:29 AM

"It's very simple. When people are admitted to hospital the higher their viral load the more likely they are to get very sick, the more likely they are to die. And this is so important because we've looked at the idea that the viral load someone is infected with is going to determine how sick they are going to get. Meaning that simple things like handwashing and wearing a mask can protect me as the non-infected mask wearer because I will get a lower infecting dose of the virus therefore more likely to get an asymptomatic or minimally symptomatic course of disease, but a course of disease which should still engender immunity." If this is true, which I have no reason to doubt, then the answer to CV19 is staring us in the face. Under controlled conditions administer to everyone a low infecting dose of the virus to get an asymptomatic or minimally symptomatic course of disease which should still engender immunity. Problem solved. You're welcome. Dr. John Campbell Recent research, youtube Sep 5, 2020 Third Paper: Viral load and mortality @2:00

re: Why Are Moderna Executives Dumping Stock While Developing a Coronavirus Vaccine?

Shasha — 9/4/2020 11:18:32 PM

The curve is flattened...no more Corona virus mostly. www.youtube.com/watch The vaccine is dangerous/not needed and killing people/destroying health is not good. It may not help and may hurt. They want out before people say NO to the vaccine.

re: Why Are Moderna Executives Dumping Stock While Developing a Coronavirus Vaccine?

danhow94535 — 9/4/2020 11:03:39 PM

We as American Tax payers need to put a stop to funding these diabolical companies. I am glad that somebody is keeping and eye on this and let the lawsuits begin. 2.5 billion could sure help a lot of American families and we should demand that every American Tax payer receives a portion of it back.